gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with myristic acid in 1 studies
| Studies (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Trials (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Recent Studies (post-2010) (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Studies (myristic acid) | Trials (myristic acid) | Recent Studies (post-2010) (myristic acid) |
|---|---|---|---|---|---|
| 638 | 31 | 243 | 1,727 | 24 | 409 |
| Protein | Taxonomy | gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate (IC50) | myristic acid (IC50) |
|---|---|---|---|
| Toll-like receptor 2 | Homo sapiens (human) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck, A; Echner, H; Gharabaghi, A; Heckl, S; Kalbacher, H; Klose, U; Sturzu, A | 1 |
1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and myristic acid
| Article | Year |
|---|---|
Cellular uptake of cationic gadolinium-DOTA peptide conjugates with and without N-terminal myristoylation.
Topics: Amino Acid Sequence; Biological Transport; Cations; Cell Line, Tumor; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Heterocyclic Compounds; Humans; Molecular Sequence Data; Myristic Acid; Organometallic Compounds; Peptides; tat Gene Products, Human Immunodeficiency Virus | 2009 |